{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:13:30Z","timestamp":1794903210493,"version":"4.9.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Study Design:<\/jats:title>\n            <jats:p>Retrospective analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To evaluate the effects of GLP-1 agonist therapy upon the incidence of pseudarthrosis in patients undergoing multilevel cervical spinal fusion<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary of Background Data:<\/jats:title>\n            <jats:p>The rising prevalence of obesity and diabetes mellitus has rendered the usage of glucagon-like peptide-1 receptor (GLP-1) agonists increasingly commonplace since their introduction in 2005. However, there is a dearth of evidence to suggest whether outcomes of multilevel cervical spinal fusion differ in patients treated with GLP-1 agonists. This study assesses rates of pseudarthrosis in patients who underwent multilevel cervical spine fusion with and without concurrent GLP-1 agonist therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The TriNetX, LLC Diamond Network database was queried utilizing CPT codes for patients undergoing both anterior and posterior multilevel cervical spinal fusion from 2005 to 2024. Patients prescribed liraglutide, pramlintide, tirzepatide, semaglutide, lixisenatide, or dulaglutide within 1 year of surgery were propensity matched to patients without GLP-1 agonist prescriptions. Cohort balancing was achieved categorically according to age at procedure, race, sex, and nicotine dependence. Cohort balancing was performed continuously to account for body mass index and hemoglobin A1C at the time of procedure. CPT diagnosis codes for pseudarthrosis after attempted fusion were concomitantly utilized to assess pseudarthrosis rates at 6-months, 1-year, and 2-years postoperatively using the Fisher exact test. Statistical significance was set at <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In consideration of anterior multilevel cervical fusion, 1204 patients utilized GLP-1 agonist therapy, while 1204 patients did not use GLP-1 agonists. With respect to posterior multilevel cervical fusion, 1378 patients utilized GLP-1 agonist therapy, and 1378 patients did not have a GLP-1 agonist prescription. Anterior postoperative pseudarthrosis rates were significantly decreased in the GLP-1 agonist cohort versus the non-GLP-1 agonist cohort at 6-months (10.71% vs. 17.61%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), 1-year (12.04% vs. 18.52%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and 2-years (12.87% vs. 19.19%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Posterior postoperative pseudarthrosis rates were also significantly decreased in the GLP-1 agonist cohort versus the non-GLP-1 agonist cohort at 6-months (13.21% vs. 22.28%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), 1-year (14.37% vs. 24.45%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and 2-years (16.87% vs. 24.43%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our findings demonstrate a statistically significant lower incidence of pseudarthrosis among patients treated with GLP-1 agonist therapy at all timepoints within this study\u2014from 6-months to 2-years postoperatively, suggesting a potentially beneficial effect of GLP-1 agonist therapy in promoting fusion success in multilevel cervical spine surgery. Fundamentally, this aligns with the pharmacodynamic nature of GLP-1 agonists: as compounds that enhance osteoblastic activity and suppress osteoclastic activity, thereby facilitating bone formation and attenuating bone resorption. Further investigation into the mechanistic underpinnings of GLP-1 agonists\u2019 effects on bone metabolism may pave the way for enhancing the success of cervical spine surgery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bsd.0000000000001775","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:00:36Z","timestamp":1741179636000},"page":"213-216","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion"],"prefix":"10.1097","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6871-0629","authenticated-orcid":false,"given":"Sohrab K.","family":"Vatsia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Levidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse E.","family":"Bible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin","volume":"6","author":"Meng","year":"2016","journal-title":"Stem Cell Rep"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ajhp\/zxac102","article-title":"National trends in prescription drug expenditures and projections for 2022","volume":"79","author":"Tichy","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"R4-20250501","first-page":"8","article-title":"Poll: Roughly 12% of US adults have used a glp-1 drug, even if unaffordable","volume":"332","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"R5-20250501","first-page":"2914","article-title":"Glucagon-like peptide-1 receptor signaling regulates bone metabolism in mice","volume":"154","author":"Sleph","year":"2013","journal-title":"Endocrinology"},{"key":"R6-20250501","first-page":"1450","article-title":"Glucagon-like peptide-1 receptor activation increases bone mass and strength in mice","volume":"25","author":"Xu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R7-20250501","first-page":"110492","article-title":"Effects of GLP-1 receptor agonists on bone metabolism and osteoporosis: a systematic review and meta-analysis","volume":"198","author":"Zhang","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2147\/DMSO.S404392","article-title":"Liraglutide in combination with insulin has a superior therapeutic effect to either alone on fracture healing in diabetic rats","volume":"16","author":"Liu","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R9-20250501","first-page":"920","article-title":"Tirzepatide and bone health: analysis of bone density and remodeling markers in clinical trials","volume":"108","author":"Smith","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20250501","first-page":"1556","article-title":"Effects of semaglutide on bone health in individuals with type 2 diabetes: a 2-year observational study","volume":"25","author":"Williams","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R11-20250501","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CORR.0000000000002957","article-title":"Patients with preexisting anxiety and mood disorders are more likely to develop complex regional pain syndrome after fractures","volume":"482","author":"Pereira","year":"2024","journal-title":"Clin Orthop Relat Res"},{"key":"R12-20250501","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1016\/j.arth.2024.03.012","article-title":"Post-traumatic stress disorder is associated with increased emergency department services and similar rates of opioid prescriptions following primary total hip arthroplasty: a propensity matched analysis","volume":"39","author":"Monahan","year":"2024","journal-title":"J Arthroplasty"},{"key":"R13-20250501","first-page":"e313","article-title":"The epidemiology of posttraumatic osteoarthritis of the knee in the United States: an analysis of 948,853 patients from 2000 to 2022","volume":"32","author":"Bank","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/BSD.0000000000001259","article-title":"Pseudarthrosis of the Cervical Spine","volume":"35","author":"Zuckerman","year":"2022","journal-title":"Clin Spine Surg"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2152-7806.76147","article-title":"Pros, cons, and costs of INFUSE in spinal surgery","volume":"2","author":"Epstein","year":"2011","journal-title":"Surg Neurol Int"},{"issue":"s1","key":"R16-20250501","doi-asserted-by":"crossref","first-page":"104","DOI":"10.14444\/8058","article-title":"Synthetic bone graft materials in spine fusion: current evidence and future trends","volume":"15","author":"Plantz","year":"2021","journal-title":"Int J Spine Surg"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0036-1580610","article-title":"Autograft versus allograft for cervical spinal fusion: a systematic review","volume":"7","author":"Tuchman","year":"2017","journal-title":"Global Spine J"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2192568218819817","article-title":"Current strategies in prevention of postoperative infections in spine surgery","volume":"10","author":"Atesok","year":"2020","journal-title":"Global Spine J"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00776-013-0518-7","article-title":"High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery","volume":"19","author":"Hikata","year":"2014","journal-title":"J Orthop Sci"}],"container-title":["Clinical Spine Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000001775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:01:12Z","timestamp":1746100872000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BSD.0000000000001775"}},"subtitle":["A Propensity-Matched Analysis"],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bsd.0000000000001775","relation":{},"ISSN":["2380-0186","2380-0194"],"issn-type":[{"value":"2380-0186","type":"print"},{"value":"2380-0194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"2025-01-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}